Analyst Ratings For Amylyx Pharma
Analyst Ratings For Amylyx Pharma
Amylyx Pharma的分析師評級
Analysts' ratings for Amylyx Pharma (NASDAQ:AMLX) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
過去季度Amylyx Pharma (NASDAQ:AMLX)的分析師評級從看好到看淡不一，來自五位分析師提供。
The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.
以下表格總結了分析師們最近的評級，揭示了過去30天內情緒的變化並將其與前幾個月進行了比較。
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $6.2, a high estimate of $8.00, and a low estimate of $3.00. No alteration is observed as the current average remains at the previous average price target.
分析師通過他們對12個月價格目標的評估提供更深入的見解，揭示出平均目標價爲$6.2，最高預估價爲$8.00，最低預估價爲$3.00。當前平均價格目標與先前平均價格目標保持一致，未有變化。
Breaking Down Analyst Ratings: A Detailed Examination
分析師評級分析：詳細分析
In examining recent analyst actions, we gain insights into...
通過分析最近分析師...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。